ABIOMED Performance
The firm shows a Beta (market volatility) of 0.27, which signifies not very significant fluctuations relative to the market. As returns on the market increase, ABIOMED's returns are expected to increase less than the market. However, during the bear market, the loss of holding ABIOMED is expected to be smaller as well. ABIOMED at this moment shows a risk of 0.0%. Please confirm ABIOMED standard deviation, value at risk, kurtosis, as well as the relationship between the jensen alpha and semi variance , to decide if ABIOMED will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days ABIOMED has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, ABIOMED is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
| Begin Period Cash Flow | 232.7 M | |
| Total Cashflows From Investing Activities | -381 M |
ABIOMED |
ABIOMED Relative Risk vs. Return Landscape
If you would invest (100.00) in ABIOMED on January 26, 2024 and sell it today you would earn a total of 100.00 from holding ABIOMED or generate -100.0% return on investment over 90 days. ABIOMED is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than ABIOMED, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
ABIOMED Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for ABIOMED's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as ABIOMED, and traders can use it to determine the average amount a ABIOMED's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| ABMD |
Based on monthly moving average ABIOMED is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ABIOMED by adding ABIOMED to a well-diversified portfolio.
ABIOMED Fundamentals Growth
ABIOMED Stock prices reflect investors' perceptions of the future prospects and financial health of ABIOMED, and ABIOMED fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ABIOMED Stock performance.
| Return On Equity | 0.18 | |||
| Return On Asset | 0.0955 | |||
| Profit Margin | 0.25 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 16.32 B | |||
| Shares Outstanding | 45.09 M | |||
| Price To Earning | 76.38 X | |||
| Price To Book | 11.13 X | |||
| Price To Sales | 15.96 X | |||
| Revenue | 1.03 B | |||
| EBITDA | 268.49 M | |||
| Cash And Equivalents | 844.32 M | |||
| Cash Per Share | 18.57 X | |||
| Total Debt | 10 M | |||
| Debt To Equity | 0.01 % | |||
| Book Value Per Share | 34.09 X | |||
| Cash Flow From Operations | 285.39 M | |||
| Earnings Per Share | 5.83 X | |||
| Total Asset | 1.67 B | |||
| Retained Earnings | 650.05 M | |||
| Current Asset | 288.39 M | |||
| Current Liabilities | 46.54 M | |||
About ABIOMED Performance
To evaluate ABIOMED Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when ABIOMED generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare ABIOMED Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand ABIOMED market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents ABIOMED's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. The company was founded in 1981 and is headquartered in Danvers, Massachusetts. Abiomed operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 2003 people.Things to note about ABIOMED performance evaluation
Checking the ongoing alerts about ABIOMED for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for ABIOMED help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| ABIOMED is not yet fully synchronised with the market data | |
| ABIOMED has some characteristics of a very speculative penny stock | |
| ABIOMED has a very high chance of going through financial distress in the upcoming years | |
| Over 97.0% of the company shares are held by institutions such as insurance companies |
- Analyzing ABIOMED's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ABIOMED's stock is overvalued or undervalued compared to its peers.
- Examining ABIOMED's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating ABIOMED's management team can have a significant impact on its success or failure. Reviewing the track record and experience of ABIOMED's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of ABIOMED's stock. These opinions can provide insight into ABIOMED's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Consideration for investing in ABIOMED Stock
If you are still planning to invest in ABIOMED check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ABIOMED's history and understand the potential risks before investing.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |